Logo image
Description of the Age-Related Eye Disease Study 9-step severity scale applied to participants in the Complications of Age-related Macular Degeneration Prevention Trial
Journal article   Open access   Peer reviewed

Description of the Age-Related Eye Disease Study 9-step severity scale applied to participants in the Complications of Age-related Macular Degeneration Prevention Trial

Gui-shuang Ying, Maureen G Maguire, Judith Alexander, Revell W Martin, Andrew N Antoszyk and Complications of Age-related Macular Degeneration Prevention Trial Research Group
Archives of ophthalmology (1960), Vol.127(9), pp.1147-1151
09/2009
DOI: 10.1001/archophthalmol.2009.189
PMID: 19752423
url
https://doi.org/10.1001/archophthalmol.2009.189View
Published (Version of record) Open Access

Abstract

To describe characteristics of the Age-Related Eye Disease Study (AREDS) 9-step severity scale applied to participants in the Complications of Age-related Macular Degeneration Prevention Trial (CAPT). Eligibility criteria for CAPT required 10 or more large (>or=125 microm) drusen in each eye. Readers graded baseline photographs from all participants and all follow-up photographs from 402 untreated eyes. Drusen and pigment characteristics were used to assign the AREDS scale score. Choroidal neovascularization was identified from fluorescein angiograms. Geographic atrophy involving the macular center was identified from color photographs. Among 1001 untreated eyes, 90% were at steps 5 to 7 at baseline. The 5-year incidence of advanced age-related macular degeneration (AMD) increased with each step from 8% (step 4) to 40% (steps 8 and 9 combined). These rates were similar to those reported in AREDS. Among 261 eyes with all 5 annual photograph gradings available and without progression to advanced AMD, 55% of eyes had scores that indicated improvement at least once. Before progression to advanced AMD, only 32% of 141 eyes either went through step 8 or 9 or had an increase of 2 or more steps from baseline. The AREDS 9-step severity scale was predictive of development of advanced AMD. The AREDS scale has deficiencies as a surrogate outcome for progression to advanced AMD.
Photography Severity of Illness Index Macular Degeneration - prevention & control Choroidal Neovascularization - diagnosis Follow-Up Studies Macular Degeneration - classification Risk Assessment Humans Retinal Drusen - classification Choroidal Neovascularization - prevention & control Laser Coagulation Disease Progression Macular Degeneration - diagnosis Incidence Atrophy Retinal Pigment Epithelium - pathology Choroidal Neovascularization - classification Retinal Drusen - diagnosis Observation Fluorescein Angiography

Details

Logo image